These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 6680095

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW.
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Improved purification process for cholera toxin and its application to the quantification of residual toxin in cholera vaccines.
    Jang H, Kim HS, Kim JA, Seo JH, Carbis R.
    J Microbiol Biotechnol; 2009 Jan; 19(1):108-12. PubMed ID: 19190416
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. GM(1)-functionalized liposomes in a microtiter plate assay for cholera toxin in Vibrio cholerae culture samples.
    Edwards KA, March JC.
    Anal Biochem; 2007 Sep 01; 368(1):39-48. PubMed ID: 17603995
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE, Lucas C, Bleakley CR.
    Vaccine; 2004 Jun 02; 22(17-18):2137-45. PubMed ID: 15149770
    [Abstract] [Full Text] [Related]

  • 31. Neutralization of the vascular permeability factor of Vibrio Cholerae in man.
    Martin AR, Vernon TM, Mosley WH.
    Am J Trop Med Hyg; 1969 Mar 02; 18(2):253-7. PubMed ID: 5777737
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antigenicity of cholera toxoid in humans.
    Germanier R, Fürer E, Varallyay S, Inderbitzin TM.
    J Infect Dis; 1977 Apr 02; 135(4):512-6. PubMed ID: 856918
    [Abstract] [Full Text] [Related]

  • 34. Effect of Vibrio cholerae toxin on oral immunization of chickens.
    Meinersmann RJ, Porter RE.
    Avian Dis; 1993 Apr 02; 37(2):427-32. PubMed ID: 8363507
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G, Wang S, Zhuang L, Hackett A, Gu L, Zhang L, Zhang C, Wang H, Huang Z, Lu S.
    Vaccine; 2009 Jun 12; 27(29):3821-30. PubMed ID: 19443090
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cholera antitoxin titrations: a comparative study of fat-cell, ileal-loop, and rabbit-skin assays.
    Curlin CT, Mosley WH, Greenough WB.
    J Infect Dis; 1973 Mar 12; 127(3):294-8. PubMed ID: 4734668
    [No Abstract] [Full Text] [Related]

  • 39. Active and passive immunization in the adult rabbit ileal loop model as an assay for production of antitoxin immunity by cholera vaccines.
    Mosley WH, Ahmed A.
    J Bacteriol; 1969 Oct 12; 100(1):547-9. PubMed ID: 5344118
    [Abstract] [Full Text] [Related]

  • 40. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
    Majumdar AS, Dutta P, Dutta D, Ghose AC.
    Infect Immun; 1981 Apr 12; 32(1):1-8. PubMed ID: 7216479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.